Skip to main content
SpringerLink
Log in

Plasma Cell Myeloma and Other Plasma Cell Dyscrasias

  • Chapter
  • First Online:
Neoplastic Hematopathology

Part of the book series: Contemporary Hematology ((CH))

  • 2192 Accesses

Scope of Chapter/Abstract

This chapter covers plasma cell neoplasms, including plasma cell myeloma and lymphoplasmacytic lymphoma (LPL)/ Waldenström macroglobulinemia (WM) involving the bone marrow. LPL involving extramedullary sites is discussed in Chap. 15.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s Macroglobulinemia. Semin Oncol 2003;30:110-5.

    Article  PubMed  Google Scholar 

  2. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.

    Google Scholar 

  3. Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. IARC: Lyon, 2008.

    Google Scholar 

  4. Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeher K, Sommerfeld W. Histologic classification and Staging of multiple myeloma: A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987;87:342-55.

    PubMed  CAS  Google Scholar 

  5. San Miguel JF, Gutierrez NC, Mateo G, Orfao A. Conventional diagnostics in multiple myeloma. Eur J Cancer 2006;42:1510-9.

    Article  PubMed  Google Scholar 

  6. Pratt G. The evolving use of serum free light chain assays in haematology. Br J Haematol 2008;141:413-22.

    Article  PubMed  CAS  Google Scholar 

  7. Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Ann Hematol 2005;84:588-93.

    Article  PubMed  CAS  Google Scholar 

  8. Peterson LC, Brown BA, Crosson JT, Mladenovic J. Application of the immunoperoxidase technique to bone marrow trephine biopsies in the classification of patients with monoclonal gammopathies. Am J Clin pathol 1986;85:688-93.

    PubMed  CAS  Google Scholar 

  9. Eckert F, Schmid I, Kradolfer D, Schmid U. Bone marrow plasmacytosis - an immunohistological study. Blut 1986;53:11-9.

    Article  PubMed  CAS  Google Scholar 

  10. Majumdar G, Grace RJ, Singh AK, Slater NG. The value of the bone marrow plasma cell cytoplasmic light chain ratio in differentiating between multiple myeloma and monoclonal gammopathy of undetermined significance. Leuk Lymphoma 1992;8:491-3.

    Article  PubMed  CAS  Google Scholar 

  11. Lin P, Owens R, Tricot G, Wilson CS. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004;121:482-8.

    Article  PubMed  Google Scholar 

  12. Mateo G, Castellanos M, Rasillo A, et al. Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res 2005;11:3661-7.

    Article  PubMed  CAS  Google Scholar 

  13. Almeida J, Orfao A, Mateo G, et al. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Pathol Biol 1999;47:119-27.

    PubMed  CAS  Google Scholar 

  14. Pellat-Deceunynck C, Bataille R, Robillard N, et al. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood 1994;84:2597-603.

    PubMed  CAS  Google Scholar 

  15. Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: A workshop Report. Cancer Res 2004;64:1546-58.

    Article  PubMed  CAS  Google Scholar 

  16. Ho PJ, Campbell LJ, Gibson J, Brown R, Joshua D. The biology and cytogenetics of multiple myeloma. Rev Clin Exp Hematol 2002;6:276-300.

    Article  PubMed  CAS  Google Scholar 

  17. Avet-Loiseau H, Attal M, Moreau P, et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 2007;109:3489-95.

    Article  PubMed  CAS  Google Scholar 

  18. Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 2005;23:6333-8.

    Article  PubMed  CAS  Google Scholar 

  19. Keren DF. Intestinal mucosal immune defense mechanisms. Am J Surg Pathol 1988; 12:100-5.

    Google Scholar 

  20. Bharti R, Smith D. Mucous membrane plasmacytosis: A case report and review of the literature. Dermatol Online J 2003;9:15.

    PubMed  Google Scholar 

  21. Solomon LW, Wein RO, Rosenwald I, Laver N. Plasma cell mucositis of the oral cavity: a report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:853-60.

    Article  PubMed  Google Scholar 

  22. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-20.

    Article  PubMed  Google Scholar 

  23. Durie BG, Samlon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842-54.

    Article  PubMed  CAS  Google Scholar 

  24. Fonseca R, San Miguel J. Prognostic factors and staging in multiple myeloma. Hematol Oncol Clin N Am 2007;21:1115-40.

    Article  Google Scholar 

  25. Shaughnessy J. Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma. Hematology 2005;10:117-26.

    Article  PubMed  CAS  Google Scholar 

  26. Bergsagel PL, Kuehl WM. Chromosome translocations in multiple myeloma. Oncogene 2001;20:5611-22.

    Article  PubMed  CAS  Google Scholar 

  27. Chesi M, Nardini E, Brents L, et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997;16:260-4.

    Article  PubMed  CAS  Google Scholar 

  28. Liu P, Leong T, Quam L, et al. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III trial. Blood 1996;88:2699-706.

    PubMed  CAS  Google Scholar 

  29. Gutierrez NC, Garcia-Sanz R, San Miguel JF. Molecular biology of myeloma. Clin Transl Oncol 2007;9:618-24.

    Article  PubMed  CAS  Google Scholar 

  30. Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005;106:296-303.

    Article  PubMed  CAS  Google Scholar 

  31. Fenk R, Haas R, Kronenwett R. Molecular monitoring of minimal residual disease in patients with multiple myeloma. Hematology 2004;9:17-33.

    Article  PubMed  CAS  Google Scholar 

  32. Davies FE, Rawstron AC, Owen RG, Morgan GJ. Minimal residual disease monitoring in multiple myeloma. Best Pract Res Clin Hematol 2002;15:197-222.

    Article  CAS  Google Scholar 

  33. Slovak ML, Bedell V, Pagel K, Chang KL, Smith D, Somlo G. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization. Cancer Genet Cytogenet 2005;158:99-109.

    Article  PubMed  CAS  Google Scholar 

  34. Vitolo U, Ferreri AJ, Montoto S. Lymphoplasmacytic lymphoma-Waldenstrom macroglobulinemia. Crit Rev Oncol Hematol. 2008;67:172-85.

    Article  PubMed  Google Scholar 

  35. Vijay A, Gertz MA. Waldenstrom macroglobulinemia. Blood 2007;109:5096-103.

    Article  PubMed  CAS  Google Scholar 

  36. Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Diagnosis and management of Waldenstrom’s macroglobulinemia. J Clin Oncol 2005;23:1564-77.

    Article  PubMed  Google Scholar 

  37. Konoplev S, Medeiros LJ, Bueso-Ramos CE, Jorgensen JL, Lin P. Immunophenotypic profile of lymphoplasmacytic lymphoma/ Waldenstrom macroglobulinemia. Am J Clin Pathol 2005;124:414-20.

    Article  PubMed  Google Scholar 

  38. Terre C, Nguyen-Khac F, Barin C, et al. Trisomy 4, a new chromosomal abnormality in Waldenstrom’s macroglobulinemia: a study of 39 cases. Leukemia 2006;20:1634-6.

    Article  PubMed  CAS  Google Scholar 

  39. Mansoor A, Medeiros LJ, Weber D, et al. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Am J Clin pathol 2001;116:543-9.

    Article  PubMed  CAS  Google Scholar 

  40. Chng WJ, Schop RF, Price-Troska T, et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006;108:2755-63.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    Marwan A. Yared

Authors
  1. Marwan A. Yared
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marwan A. Yared .

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, The University of Texas, Holcombe Blvd. 1515 , Houston, 77030, U.S.A.

    Dan Jones

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Yared, M.A. (2010). Plasma Cell Myeloma and Other Plasma Cell Dyscrasias. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-384-8_19

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-383-1

  • Online ISBN: 978-1-60761-384-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation